Press release from Business Wire
Medidata Solutions Schedules Third Quarter Earnings Conference Call for October 24, 2013
Thursday, October 10, 2013
Medidata Solutions Schedules Third Quarter Earnings Conference Call for October 24, 201308:30 EDT Thursday, October 10, 2013
NEW YORK (Business Wire) -- Medidata Solutions (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it will release its third quarter 2013 financial results before the open of the market on Thursday, October 24, 2013. Tarek Sherif, chief executive officer, and Cory Douglas, chief financial officer, will also hold a conference call at 8:00 a.m. ET for investors and analysts to discuss these results and business outlook.
To participate by telephone, domestic participants may dial 1-877-303-2528 and international participants may dial 1-847-829-0023. Those interested in participating in the conference call should dial in at least 10 minutes prior to the call to register.
Participants can also join the call via a simultaneous live audio webcast, which will be made available on the “Investor” section of Medidata's website, http://investor.mdsol.com.
A replay of the conference call can be accessed through November 7, 2013, by dialing 1-800-585-8367 domestically or 1-404-537-3406 internationally, with the passcode 74359697. An archive of the call will also be hosted on the “Investor” section of Medidata's website, http://investor.mdsol.com, for a limited period of time.
About Medidata Solutions
Medidata Solutions is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud™ brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. We are committed to advancing the competitive and scientific goals of our global customers, which include over 90% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations.
Hulus Alpay, 212-419-1025
Gail Janowitz, 212-918-1792